WooGene B&G Co. Ltd
WooGene B&G Co., Ltd. develops, manufactures, and markets products to animal health and livestock industry in South Korea and internationally. The company's products include veterinary medicines, raw materials, and probiotic. It offers veterinary medicines for poultry, swine, bovine, horse, dog, cat, sheep, deer, and aquaculture markets; and vaccines for swine, poultry, canine, and cow markets. T… Read more
WooGene B&G Co. Ltd (018620) - Total Assets
Latest total assets as of September 2025: ₩117.10 Billion KRW
Based on the latest financial reports, WooGene B&G Co. Ltd (018620) holds total assets worth ₩117.10 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
WooGene B&G Co. Ltd - Total Assets Trend (2011–2024)
This chart illustrates how WooGene B&G Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
WooGene B&G Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
WooGene B&G Co. Ltd's total assets of ₩117.10 Billion consist of 36.2% current assets and 63.8% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩16.81 Billion | 14.9% |
| Accounts Receivable | ₩6.87 Billion | 6.1% |
| Inventory | ₩11.43 Billion | 10.1% |
| Property, Plant & Equipment | ₩40.26 Billion | 35.7% |
| Intangible Assets | ₩12.46 Billion | 11.0% |
| Goodwill | ₩11.75 Billion | 10.4% |
Asset Composition Trend (2011–2024)
This chart illustrates how WooGene B&G Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: WooGene B&G Co. Ltd's current assets represent 36.2% of total assets in 2024, a decrease from 42.8% in 2011.
- Cash Position: Cash and equivalents constituted 14.9% of total assets in 2024, up from 2.2% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is property, plant & equipment at 35.7% of total assets.
WooGene B&G Co. Ltd Competitors by Total Assets
Key competitors of WooGene B&G Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620
|
Korea | ₩269.00 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Sam-A Pharm. Co. Ltd
KQ:009300
|
Korea | ₩246.13 Billion |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040
|
Korea | ₩291.47 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
|
EstechPharma Co. Ltd
KQ:041910
|
Korea | ₩192.01 Billion |
|
Komipharm International Co. Ltd
KQ:041960
|
Korea | ₩133.65 Billion |
WooGene B&G Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - WooGene B&G Co. Ltd generates 0.49x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - WooGene B&G Co. Ltd is currently not profitable relative to its asset base.
WooGene B&G Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.23 | 1.25 | 1.11 |
| Quick Ratio | 0.94 | 0.87 | 0.74 |
| Cash Ratio | 0.00 | 0.47 | 0.00 |
| Working Capital | ₩8.16 Billion | ₩ 7.82 Billion | ₩ 2.95 Billion |
WooGene B&G Co. Ltd - Advanced Valuation Insights
This section examines the relationship between WooGene B&G Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.85 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -7.2% |
| Total Assets | ₩112.87 Billion |
| Market Capitalization | $10.47 Million USD |
Valuation Analysis
Below Book Valuation: The market values WooGene B&G Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: WooGene B&G Co. Ltd's assets decreased by 7.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for WooGene B&G Co. Ltd (2011–2024)
The table below shows the annual total assets of WooGene B&G Co. Ltd from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩112.87 Billion | -7.17% |
| 2023-12-31 | ₩121.58 Billion | +32.84% |
| 2022-12-31 | ₩91.52 Billion | +19.62% |
| 2021-12-31 | ₩76.51 Billion | -1.36% |
| 2020-12-31 | ₩77.56 Billion | -8.89% |
| 2019-12-31 | ₩85.13 Billion | +41.77% |
| 2018-12-31 | ₩60.05 Billion | -0.97% |
| 2017-12-31 | ₩60.64 Billion | +4.29% |
| 2016-12-31 | ₩58.15 Billion | +37.65% |
| 2015-12-31 | ₩42.24 Billion | +45.35% |
| 2014-12-31 | ₩29.06 Billion | +11.03% |
| 2012-12-31 | ₩26.18 Billion | +1.44% |
| 2011-12-31 | ₩25.81 Billion | -- |